MK2 inhibitors, the synthesis thereof, and intermediates thereto
US12049470B2 · kind B2 · utility
0Cited by
14References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 28, 2022 |
| Grant date | Jul 30, 2024 |
| Priority date | — |
| Expiry date | Feb 3, 2042 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/55
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present disclosure provides novel synthetic intermediates useful in the synthesis of MK2 kinase inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.